Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

Abstract Background Predicting imminent hepatocellular carcinoma (HCC) in liver cirrhotic patients is an unmet medical need. We aimed to investigate circulatory biomarkers and their optimum combinations in a prospective study. Methods We investigated plasma interleukin 17 (IL-17) concentrations, qua...

Full description

Bibliographic Details
Main Authors: Kung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, Yu-De Chu, Chih-Lang Lin, Wey-Ran Lin, Ya-Hui Huang, Tong-Hung Wang, Rong-Nan Chien, Tsung-Hui Hu, Chau-Ting Yeh
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Gastroenterology
Subjects:
Immunology
Inflammation
Th17
Oncogenesis
Online Access:https://doi.org/10.1186/s12876-021-01761-1

Internet

https://doi.org/10.1186/s12876-021-01761-1

Similar Items